SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med. 2004; 350: 351360.
  • 2
    Winton T,Livingston R,Johnson D, et al. Vinorelbine plus cisplatin versus observation in resected non-small cell lung cancer. N Engl J Med. 2005; 352: 25892597.
  • 3
    Douillard J,Rosell R,Delena M, et al. ANITA: phase III adjuvant vinorelbine and cisplatin versus observation in completely resected (stage I-III) non-small cell lung cancer patients: final results after 70-month median follow-up (Abstract 7013). J Clin Oncol. 2005; 23(16S): 624S.
  • 4
    Strauss GM,Herdon JE,Maddaus MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer: update of CALGB protocol 9633 (abstract 7007). J Clin Oncol. 2006; 24(18S): 365S.
  • 5
    Kato H,Ichinose Y,Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004; 350: 17131720.
  • 6
    PORT Meta-Analysis Trialists Group. Post-operative radiotherapy in non-small cell lung cancer: systemic review and meta-analysis of individual patient data from 9 randomized controlled trials. Lancet. 1998; 352: 257263.
  • 7
    Lally BE,Zelterman D,Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the Surveillance, Epidemiology, and End Results database. J Clin Oncol. 2006; 24: 29983006.
  • 8
    Douillard J,Rosell R,De Lena M, et al. Plenary 3: impact of radiation on survival after complete resection of non–small-cell lung cancer: descriptive analysis in the randomized adjuvant chemotherapy trial, ANITA 1 (abstract). Int J Radiat Oncol Biol Phys. 2006; 66( 3 suppl): S2.
  • 9
    Varlotto JM,Recht A,Nikolov M, et al. The effects of changing the World Health Organization definition of bronchioloalveolar carcinoma (abstract 7632). J Clin Oncol. 2007; 25(18S): 417s.
  • 10
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER Public-use Data (1973–2003). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Statistics Branch; 2006. Available at: http://seer.cancer.gov/publicdata/. Accessed May 3, 2006.
  • 11
    Surveillance, Epidemiology, and End Results (SEER) Program Web Site. Data quality. Available at: http://seer.cancer.gov/about/quality.html. Accessed May 3, 2006.
  • 12
    Leong SS,Rocha Lima CM,Sherman CA,Green MR. The 1997 international staging system for non-small cell lung cancer: have all the issues been addressed? Chest. 1999; 115: 242248.
  • 13
    Fisher RA. On the interpretation of chi-square from contingency tables, and the calculation of P. J R Stat Soc. 1922; 85: 8794.
  • 14
    Mantel N. Evaluation of survival data and 2 new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50: 163170.
  • 15
    Kaplan ES,Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958; 53: 457481.
  • 16
    Travis WD,Colby TV,Corrin B, et al. Histological Typing of Lung and Pleural Tumors, 3rd ed. Berlin: Springer; 1999.
  • 17
    Zell JA,Ou SH,Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 2005; 23: 83968405.
  • 18
    Keller SM,Adak S,Wagner H, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer.Eastern Cooperative Oncology Group. N Engl J Med. 2000; 343: 12171222.
  • 19
    Scagliotti GV,Fossati R,Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst. 2003; 95: 14531461.
  • 20
    Waller D,Peake MD,Stephens RJ, et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothor Surg. 2004; 26: 173182.
  • 21
    Dautzenberg B,Arriagada R,Chammard AB, et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer. 1999; 86: 265273.
  • 22
    Van Houtte P,Rocmans P,Smets P, et al. Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys. 1980; 6: 983986.
  • 23
    Lafitte JJ,Ribet ME,Prevost BM, et al. Postresection irradiation for T2N0M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg. 1996; 62: 830834.
  • 24
    Debevec M,Bitenc M,Vidmar S, et al. Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988–1992. Lung Cancer. 1996; 14: 99107.
  • 25
    Stephens RJ,Girling DJ,Bleehen NM, et al. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease Medical Research Council Lung Cancer Working Party. Br J Cancer. 1996; 74: 632639.
  • 26
    Feng QF,Wang M,Wang LJ, et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys. 2000; 47: 925929.
  • 27
    Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med. 1986; 315: 13771381.
  • 28
    Trodella L,Granone P,Valente S, et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol. 2002; 62: 1119.
  • 29
    Mayer R,Smolle-Juettner F-M,Szolar D, et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest. 1997; 112: 954959.